The senescence-associated secretory phenotype and its physiological and pathological implications.

Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019).

pubmed: 31675495 doi: 10.1016/j.cell.2019.10.005

Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614–636 (1965).

pubmed: 14315085 doi: 10.1016/0014-4827(65)90211-9

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997).

pubmed: 9054499 doi: 10.1016/S0092-8674(00)81902-9

Demaria, M. et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 7, 165–176 (2017).

pubmed: 27979832 doi: 10.1158/2159-8290.CD-16-0241

Schmitt, C. A., Wang, B. & Demaria, M. Senescence and cancer — role and therapeutic opportunities. Nat. Rev. Clin. Oncol. 19, 619–636 (2022).

pubmed: 36045302 pmcid: 9428886 doi: 10.1038/s41571-022-00668-4

Wiley, C. D. et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23, 303–314 (2016).

pubmed: 26686024 doi: 10.1016/j.cmet.2015.11.011

Faust, H. J. et al. IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis. J. Clin. Investig. 130, 5493–5507 (2020).

pubmed: 32955487 pmcid: 7524483 doi: 10.1172/JCI134091

Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of cellular senescence. Trends Cell Biol. 28, 436–453 (2018).

pubmed: 29477613 doi: 10.1016/j.tcb.2018.02.001

Freund, A., Laberge, R.-M., Demaria, M. & Campisi, J. Lamin B1 loss is a senescence-associated biomarker. Mol. Biol. Cell 23, 2066–2075 (2012).

pubmed: 22496421 pmcid: 3364172 doi: 10.1091/mbc.e11-10-0884

Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703–716 (2003).

pubmed: 12809602 doi: 10.1016/S0092-8674(03)00401-X

Kohli, J. et al. Algorithmic assessment of cellular senescence in experimental and clinical specimens. Nat. Protoc. 16, 2471–2498 (2021).

pubmed: 33911261 pmcid: 8710232 doi: 10.1038/s41596-021-00505-5

Chang, J. et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22, 78–83 (2016).

pubmed: 26657143 doi: 10.1038/nm.4010

Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y. & Campisi, J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA 98, 12072–12077 (2001).

pubmed: 11593017 pmcid: 59769 doi: 10.1073/pnas.211053698

Coppé, J.-P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, e301 (2008).

pubmed: 19053174 pmcid: 2592359 doi: 10.1371/journal.pbio.0060301

Acosta, J. C. et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006–1018 (2008).

pubmed: 18555777 doi: 10.1016/j.cell.2008.03.038

Kuilman, T. et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019–1031 (2008).

pubmed: 18555778 doi: 10.1016/j.cell.2008.03.039

Kuilman, T. & Peeper, D. S. Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 9, 81–94 (2009).

pubmed: 19132009 doi: 10.1038/nrc2560

Mosteiro, L. et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science 354, eaaf4445 (2016).

doi: 10.1126/science.aaf4445

Glück, S. et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat. Cell Biol. 19, 1061–1070 (2017).

pubmed: 28759028 pmcid: 5826565 doi: 10.1038/ncb3586

Wang, B. et al. Pharmacological CDK4/6 inhibition reveals a p53‐dependent senescent state with restricted toxicity. EMBO J. 41, e108946 (2022).

pubmed: 34985783 pmcid: 8922251 doi: 10.15252/embj.2021108946

Hernandez-Segura, A. et al. Unmasking transcriptional heterogeneity in senescent cells. Curr. Biol. 27, 2652–2660.e4 (2017).

pubmed: 28844647 pmcid: 5788810 doi: 10.1016/j.cub.2017.07.033

Basisty, N. et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599 (2020).

pubmed: 31945054 pmcid: 6964821 doi: 10.1371/journal.pbio.3000599

Wiley, C. D. et al. Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis. Cell Metab. 33, 1124–1136.e5 (2021).

pubmed: 33811820 pmcid: 8501892 doi: 10.1016/j.cmet.2021.03.008

Takasugi, M. et al. Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2. Nat. Commun. 8, 15729 (2017).

pubmed: 28585531 pmcid: 5467215 doi: 10.1038/ncomms15728

Borghesan, M. et al. Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein IFITM3. Cell Rep. 27, 3956–3971.e6 (2019).

pubmed: 31242426 pmcid: 6613042 doi: 10.1016/j.celrep.2019.05.095

Sagini, K. et al. Oncogenic H-Ras expression induces fatty acid profile changes in human fibroblasts and extracellular vesicles. Int. J. Mol. Sci. 19, 3515 (2018).

pubmed: 30413053 pmcid: 6275056 doi: 10.3390/ijms19113515

Weiner-Gorzel, K. et al. Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells. Cancer Med. 4, 745–758 (2015).

pubmed: 25684390 pmcid: 4430267 doi: 10.1002/cam4.409

Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K. & Campisi, J. Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl Acad. Sci. USA 106, 17031–17036 (2009).

pubmed: 19805069 pmcid: 2761322 doi: 10.1073/pnas.0905299106

Nakamura, Y., Aihara, R., Iwata, H., Kuwayama, T. & Shirasuna, K. IL1B triggers inflammatory cytokine production in bovine oviduct epithelial cells and induces neutrophil accumulation via CCL2. Am. J. Reprod. Immunol. 85, e13365 (2021).

pubmed: 33099841 doi: 10.1111/aji.13365

Ortiz-Montero, P., Londoño-Vallejo, A. & Vernot, J.-P. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun. Signal 15, 17 (2017).

pubmed: 28472950 pmcid: 5418812 doi: 10.1186/s12964-017-0172-3

Wiggins, K. A. et al. IL‐1α cleavage by inflammatory caspases of the noncanonical inflammasome controls the senescence‐associated secretory phenotype. Aging Cell 18, e12946 (2019).

pubmed: 30916891 pmcid: 6516163 doi: 10.1111/acel.12946

McCarthy, D. A., Clark, R. R., Bartling, T. R., Trebak, M. & Melendez, J. A. Redox control of the senescence regulator interleukin-1α and the secretory phenotype. J. Biol. Chem. 288, 32149–32159 (2013).

pubmed: 24062309 pmcid: 3820855 doi: 10.1074/jbc.M113.493841

Mandinova, A. et al. S100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells. J. Cell Sci. 116, 2687–2696 (2003).

pubmed: 12746488 doi: 10.1242/jcs.00471

Su, Y. et al. S100A13 promotes senescence-associated secretory phenotype and cellular senescence via modulation of non-classical secretion of IL-1α. Aging 11, 549–572 (2019).

pubmed: 30670674 pmcid: 6366962 doi: 10.18632/aging.101760

Bhaumik, D. et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging 1, 402–411 (2009).

pubmed: 20148189 pmcid: 2818025 doi: 10.18632/aging.100042

Wang, A.-P. et al. Pulmonary artery smooth muscle cell senescence promotes the proliferation of PASMCs by paracrine IL-6 in hypoxia-induced pulmonary hypertension. Front. Physiol. 12, 656139 (2021).

pubmed: 33897463 pmcid: 8058366 doi: 10.3389/fphys.2021.656139

Jacob, J. et al. Senescent chondrogenic progenitor cells derived from articular cartilage of knee osteoarthritis patients contributes to senescence-associated secretory phenotype via release of IL-6 and IL-8. Acta Histochem. 124, 151867 (2022).

pubmed: 35192993 doi: 10.1016/j.acthis.2022.151867

Zhou, J. et al. Sirt1 overexpression improves senescence‐associated pulmonary fibrosis induced by vitamin D deficiency through downregulating IL‐11 transcription. Aging Cell 21, e13680 (2022).

pubmed: 35906886 pmcid: 9381906 doi: 10.1111/acel.13680

Cherry, C. et al. Transfer learning in a biomaterial fibrosis model identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies. GeroScience 45, 2559–2587 (2023).

pubmed: 37079217 pmcid: 10651581 doi: 10.1007/s11357-023-00785-7

Yamagishi, R. et al. Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma. Sci. Immunol. 7, eabl7209 (2022).

pubmed: 35749514 doi: 10.1126/sciimmunol.abl7209

Rossi, M. et al. Pleiotropic effects of BAFF on the senescence-associated secretome and growth arrest. eLife 12, e84238 (2023).

pubmed: 37083495 pmcid: 10121226 doi: 10.7554/eLife.84238

Chambers, E. S. et al. Recruitment of inflammatory monocytes by senescent fibroblasts inhibits antigen-specific tissue immunity during human aging. Nat. Aging 1, 101–113 (2021).

pubmed: 37118005 doi: 10.1038/s43587-020-00010-6

Jin, H. J. et al. Senescence-associated MCP-1 secretion is dependent on a decline in BMI1 in human mesenchymal stromal cells. Antioxid. Redox Signal. 24, 471–485 (2016).

pubmed: 26573462 pmcid: 4800271 doi: 10.1089/ars.2015.6359

Zheng, X., Wang, Q., Xie, Z. & Li, J. The elevated level of IL-1α in the bone marrow of aged mice leads to MSC senescence partly by down-regulating BMI-1. Exp. Gerontol. 148, 111313 (2021).

pubmed: 33740618 doi: 10.1016/j.exger.2021.111313

Kong, P. et al. Palbociclib enhances migration and invasion of cancer cells via senescence-associated secretory phenotype-related CCL5 in non-small-cell lung cancer. J. Oncol. 2022, 2260625 (2022).

pubmed: 37181790 pmcid: 10175017 doi: 10.1155/2022/2260625

Shen, L. et al. CCL5 secreted by senescent theca‐interstitial cells inhibits preantral follicular development via granulosa cellular apoptosis. J. Cell. Physiol. 234, 22554–22564 (2019).

pubmed: 31111482 doi: 10.1002/jcp.28819

Cheng, N., Kim, K.-H. & Lau, L. F. Senescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2. JCI Insight 7, e158207 (2022).

pubmed: 35708907 pmcid: 9431681 doi: 10.1172/jci.insight.158207

Takikawa, T. et al. Senescent human pancreatic stellate cells secrete CXCR2 agonist CXCLs to promote proliferation and migration of human pancreatic cancer AsPC-1 and MIAPaCa-2 cell lines. Int. J. Mol. Sci. 23, 9275 (2022).

pubmed: 36012531 pmcid: 9409091 doi: 10.3390/ijms23169275

Kawagoe, Y. et al. CXCL5‐CXCR2 signaling is a senescence‐associated secretory phenotype in preimplantation embryos. Aging Cell 19, e13240 (2020).

pubmed: 32959976 pmcid: 7576282 doi: 10.1111/acel.13240

Guo, H. et al. Chemokine receptor CXCR2 is transactivated by p53 and induces p38‐mediated cellular senescence in response to DNA damage. Aging Cell 12, 1110–1121 (2013).

pubmed: 23869868 doi: 10.1111/acel.12138

Lesina, M. et al. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J. Clin. Investig. 126, 2919–2932 (2016).

pubmed: 27454298 pmcid: 4966329 doi: 10.1172/JCI86477

Zang, J., Ye, J., Zhang, C., Sha, M. & Gao, J. Senescent hepatocytes enhance natural killer cell activity via the CXCL-10/CXCR3 axis. Exp. Ther. Med. 18, 3845–3852 (2019).

pubmed: 31616512 pmcid: 6781833

Hwang, H. J. et al. Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells. Cancer Lett. 490, 100–110 (2020).

pubmed: 32659248 doi: 10.1016/j.canlet.2020.06.019

Liu, J. et al. Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice. J. Clin. Investig. 132, e148073 (2022).

pubmed: 35426372 pmcid: 9012290 doi: 10.1172/JCI148073

Matsuda, S. et al. TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state. Cell Rep. 42, 112129 (2023).

pubmed: 36821441 pmcid: 10187541 doi: 10.1016/j.celrep.2023.112129

Guo, Y. et al. Senescence‐associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15. Aging Cell 18, e13013 (2019).

pubmed: 31389184 pmcid: 6826139 doi: 10.1111/acel.13013

Weng, P.-W. et al. Role of GDF15/MAPK14 axis in chondrocyte senescence as a novel senomorphic agent in osteoarthritis. Int. J. Mol. Sci. 23, 7043 (2022).

pubmed: 35806043 pmcid: 9266723 doi: 10.3390/ijms23137043

Mattia, L., Gossiel, F., Walsh, J. S. & Eastell, R. Effect of age and gender on serum growth differentiation factor 15 and its relationship to bone density and bone turnover. Bone Rep. 18, 101676 (2023).

pubmed: 37090856 pmcid: 10113774 doi: 10.1016/j.bonr.2023.101676

Igarashi, N. et al. Hepatocyte growth factor derived from senescent cells attenuates cell competition-induced apical elimination of oncogenic cells. Nat. Commun. 13, 4157 (2022).

pubmed: 35851277 pmcid: 9293948 doi: 10.1038/s41467-022-31642-4

Kim, H. et al. Inhibition of matrix metalloproteinase expression by selective clearing of senescent dermal fibroblasts attenuates ultraviolet-induced photoaging. Biomed. Pharmacother. 150, 113034 (2022).

pubmed: 35489284 doi: 10.1016/j.biopha.2022.113034

Wiley, C. D. et al. Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis. JCI Insight 4, e130056 (2019).

pubmed: 31687975 pmcid: 6975274 doi: 10.1172/jci.insight.130056

Wei, J. et al. Leukotriene D4 induces cellular senescence in osteoblasts. Int. Immunopharmacol. 58, 154–159 (2018).

pubmed: 29587204 doi: 10.1016/j.intimp.2017.12.027

Cheng, H., Huang, H., Guo, Z., Chang, Y. & Li, Z. Role of prostaglandin E2 in tissue repair and regeneration. Theranostics 11, 8836–8854 (2021).

pubmed: 34522214 pmcid: 8419039 doi: 10.7150/thno.63396

Dackor, R. T. et al. Prostaglandin E2 protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction. Am. J. Physiol. Lung Cell. Mol. Physiol. 301, L645–L655 (2011).

pubmed: 21856819 pmcid: 3213994 doi: 10.1152/ajplung.00176.2011

Wallis, R., Mizen, H. & Bishop, C. L. The bright and dark side of extracellular vesicles in the senescence-associated secretory phenotype. Mech. Ageing Dev. 189, 111263 (2020).

pubmed: 32461143 pmcid: 7347005 doi: 10.1016/j.mad.2020.111263

Jeon, O. H. et al. Senescence cell-associated extracellular vesicles serve as osteoarthritis disease and therapeutic markers. JCI Insight 4, e125019 (2019).

pubmed: 30944259 pmcid: 6483636 doi: 10.1172/jci.insight.125019

Terlecki-Zaniewicz, L. et al. Extracellular vesicles in human skin: cross-talk from senescent fibroblasts to keratinocytes by miRNAs. J. Investig. Dermatol. 139, 2425–2436.e5 (2019).

pubmed: 31220456 doi: 10.1016/j.jid.2019.05.015

Takahashi, A. et al. Exosomes maintain cellular homeostasis by excreting harmful DNA from cells. Nat. Commun. 8, 15287 (2017).

pubmed: 28508895 pmcid: 5440838 doi: 10.1038/ncomms15287

Rodier, F. et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973–979 (2009).

pubmed: 19597488 pmcid: 2743561 doi: 10.1038/ncb1909

Kang, C. et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science 349, eaaa5612 (2015).

doi: 10.1126/science.aaa5612

Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656–660 (2007).

pubmed: 17251933 pmcid: 4601097 doi: 10.1038/nature05529

Wiley, C. D. et al. Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype. Sci. Rep. 8, 2410 (2018).

pubmed: 29402901 pmcid: 5799282 doi: 10.1038/s41598-018-20000-4

Efeyan, A. et al. Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin. Cancer Res. 67, 7350–7357 (2007).

pubmed: 17671205 doi: 10.1158/0008-5472.CAN-07-0200

Coppé, J.-P. et al. Tumor suppressor and aging biomarker p16

pubmed: 21880712 pmcid: 3196093 doi: 10.1074/jbc.M111.257071

Sturmlechner, I. et al. p21 produces a bioactive secretome that places stressed cells under immunosurveillance. Science 374, eabb3420 (2021).

pubmed: 34709885 pmcid: 8985214 doi: 10.1126/science.abb3420

Buj, R., Leon, K. E., Anguelov, M. A. & Aird, K. M. Suppression of p16 alleviates the senescence-associated secretory phenotype. Aging 13, 3290–3312 (2021).

pubmed: 33550279 pmcid: 7906185 doi: 10.18632/aging.202640

Chien, Y. et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 25, 2125–2136 (2011).

pubmed: 21979375 pmcid: 3205583 doi: 10.1101/gad.17276711

Crescenzi, E. et al. NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells. Oncogene 30, 2707–2717 (2011).

pubmed: 21278794 doi: 10.1038/onc.2011.1

Rovillain, E. et al. Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 30, 2356–2366 (2011).

pubmed: 21242976 pmcid: 3080811 doi: 10.1038/onc.2010.611

Ohanna, M. et al. Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS). Genes Dev. 25, 1245–1261 (2011).

pubmed: 21646373 pmcid: 3127427 doi: 10.1101/gad.625811

Kolesnichenko, M. et al. Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence. EMBO J. 40, e104296 (2021).

pubmed: 33459422 pmcid: 7957429 doi: 10.15252/embj.2019104296

Alexander, E. et al. IκBζ is a regulator of the senescence-associated secretory phenotype in DNA damage- and oncogene-induced senescence. J. Cell Sci. 126, 3738–3745 (2013).

pubmed: 23781024

Salotti, J. & Johnson, P. F. Regulation of senescence and the SASP by the transcription factor C/EBPβ. Exp. Gerontol. 128, 110752 (2019).

pubmed: 31648009 doi: 10.1016/j.exger.2019.110752

Wang, P. et al. Protein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated inflammation. Proc. Natl Acad. Sci. USA 111, 7683–7688 (2014).

pubmed: 24828530 pmcid: 4040603 doi: 10.1073/pnas.1310972111

Chong, M. et al. CD36 initiates the secretory phenotype during the establishment of cellular senescence. EMBO Rep. 19, e45274 (2018).

pubmed: 29777051 pmcid: 5989758 doi: 10.15252/embr.201745274

Xu, W. et al. Membrane-bound CD40L promotes senescence and initiates senescence-associated secretory phenotype via NF-κB activation in lung adenocarcinoma. Cell. Physiol. Biochem. 48, 1793–1803 (2018).

pubmed: 30078020 doi: 10.1159/000492352

Lin, A. W. et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008–3019 (1998).

pubmed: 9765203 pmcid: 317198 doi: 10.1101/gad.12.19.3008

Freund, A., Patil, C. K. & Campisi, J. p38MAPK is a novel DNA damage response‐independent regulator of the senescence‐associated secretory phenotype. EMBO J. 30, 1536–1548 (2011).

pubmed: 21399611 pmcid: 3102277 doi: 10.1038/emboj.2011.69

Alspach, E. et al. p38MAPK plays a crucial role in stromal-mediated tumorigenesis. Cancer Discov. 4, 716–729 (2014).

pubmed: 24670723 pmcid: 4049323 doi: 10.1158/2159-8290.CD-13-0743

Zhang, B. et al. The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1. Nat. Commun. 9, 1723 (2018).

pubmed: 29712904 pmcid: 5928226 doi: 10.1038/s41467-018-04010-4

Laberge, R.-M. et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol. 17, 1049–1061 (2015).

pubmed: 26147250 pmcid: 4691706 doi: 10.1038/ncb3195

Herranz, N. et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 17, 1205–1217 (2015).

pubmed: 26280535 pmcid: 4589897 doi: 10.1038/ncb3225

van Vliet, T. et al. Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression. Mol. Cell 81, 2041–2052.e6 (2021).

pubmed: 33823141 doi: 10.1016/j.molcel.2021.03.018

Xu, M. et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc. Natl Acad. Sci. USA 112, E6301–E6310 (2015).

pubmed: 26578790 pmcid: 4655580 doi: 10.1073/pnas.1515386112

Yang, H., Wang, H., Ren, J., Chen, Q. & Chen, Z. J. cGAS is essential for cellular senescence. Proc. Natl Acad. Sci. USA 114, E4612–E4620 (2017).

pubmed: 28533362 pmcid: 5468617 doi: 10.1073/pnas.1705499114

Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550, 402–406 (2017).

pubmed: 28976970 pmcid: 5850938 doi: 10.1038/nature24050

Takahashi, A. et al. Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells. Nat. Commun. 9, 1249 (2018).

pubmed: 29593264 pmcid: 5871854 doi: 10.1038/s41467-018-03555-8

Zhao, B. et al. Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence. Nat. Commun. 11, 908 (2020).

pubmed: 32075966 pmcid: 7031389 doi: 10.1038/s41467-020-14652-y

Omer, A. et al. G3BP1 controls the senescence-associated secretome and its impact on cancer progression. Nat. Commun. 11, 4979 (2020).

pubmed: 33020468 pmcid: 7536198 doi: 10.1038/s41467-020-18734-9

Hari, P. et al. The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype. Sci. Adv. 5, eaaw0254 (2019).

pubmed: 31183403 pmcid: 6551188 doi: 10.1126/sciadv.aaw0254

Cecco, M. D. et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 566, 73–78 (2019).

pubmed: 30728521 pmcid: 6519963 doi: 10.1038/s41586-018-0784-9

McArthur, K. et al. BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science 359, eaao6047 (2018).

pubmed: 29472455 doi: 10.1126/science.aao6047

Victorelli, S. et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature 622, 627–636 (2023).

pubmed: 37821702 pmcid: 10584674 doi: 10.1038/s41586-023-06621-4

Gulen, M. F. et al. cGAS–STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374–380 (2023).

pubmed: 37532932 pmcid: 10412454 doi: 10.1038/s41586-023-06373-1

Hoare, M. et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat. Cell Biol. 18, 979–992 (2016).

pubmed: 27525720 pmcid: 5008465 doi: 10.1038/ncb3397

Guccini, I. et al. Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis. Cancer Cell 39, 68–82.e9 (2021).

pubmed: 33186519 doi: 10.1016/j.ccell.2020.10.012

Liu, P. et al. m6A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype. Nat. Cell Biol. 23, 355–365 (2021).

pubmed: 33795874 pmcid: 8035315 doi: 10.1038/s41556-021-00656-3

Guan, Y. et al. Senescence-activated enhancer landscape orchestrates the senescence-associated secretory phenotype in murine fibroblasts. Nucleic Acids Res. 48, gkaa858 (2020).

doi: 10.1093/nar/gkaa858

Tasdemir, N. et al. BRD4 connects enhancer remodeling to senescence immune surveillance. Cancer Discov. 6, 612–629 (2016).

pubmed: 27099234 pmcid: 4893996 doi: 10.1158/2159-8290.CD-16-0217

Zhang, B. et al. KDM4 orchestrates epigenomic remodeling of senescent cells and potentiates the senescence-associated secretory phenotype. Nat. Aging 1, 454–472 (2021).

pubmed: 34263179 pmcid: 8277122 doi: 10.1038/s43587-021-00063-1

Chibaya, L. et al. EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nat. Cancer 4, 872–892 (2023).

pubmed: 37142692 pmcid: 10516132 doi: 10.1038/s43018-023-00553-8

Zhang, N. et al. Dual inhibition of H3K9me2 and H3K27me3 promotes tumor cell senescence without triggering the secretion of SASP. Int. J. Mol. Sci. 23, 3911 (2022).

pubmed: 35409271 pmcid: 8999616 doi: 10.3390/ijms23073911

Capell, B. C. et al. MLL1 is essential for the senescence-associated secretory phenotype. Genes Dev. 30, 321–336 (2016).

pubmed: 26833731 pmcid: 4743061 doi: 10.1101/gad.271882.115

Hayakawa, T. et al. SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation. PLoS One 10, e0116480 (2015).

pubmed: 25635860 pmcid: 4312089 doi: 10.1371/journal.pone.0116480

Chen, H. et al. MacroH2A1 and ATM play opposing roles in paracrine senescence and the senescence-associated secretory phenotype. Mol. Cell 59, 719–731 (2015).

pubmed: 26300260 pmcid: 4548812 doi: 10.1016/j.molcel.2015.07.011

Zirkel, A. et al. HMGB2 loss upon senescence entry disrupts genomic organization and induces CTCF clustering across cell types. Mol. Cell 70, 730–744.e6 (2018).

pubmed: 29706538 doi: 10.1016/j.molcel.2018.03.030

Sofiadis, K. et al. HMGB1 coordinates SASP‐related chromatin folding and RNA homeostasis on the path to senescence. Mol. Syst. Biol. 17, e9760 (2021).

pubmed: 34166567 pmcid: 8224457 doi: 10.15252/msb.20209760

Aird, K. M. et al. HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci. J. Cell Biol. 215, 325–334 (2016).

pubmed: 27799366 pmcid: 5100296 doi: 10.1083/jcb.201608026

Nacarelli, T. et al. NAD

pubmed: 30778219 pmcid: 6448588 doi: 10.1038/s41556-019-0287-4

Zuccolo, E. et al. The microRNA-34a-induced senescence-associated secretory phenotype (SASP) favors vascular smooth muscle cells calcification. Int. J. Mol. Sci. 21, 4454 (2020).

pubmed: 32585876 pmcid: 7352675 doi: 10.3390/ijms21124454

Wu, H. et al. Regulation of lung epithelial cell senescence in smoking-induced COPD/emphysema by microR-125a-5p via Sp1 mediation of SIRT1/HIF-1a. Int. J. Biol. Sci. 18, 661–674 (2022).

pubmed: 35002516 pmcid: 8741857 doi: 10.7150/ijbs.65861

Lang, A. et al. MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4. Aging 8, 484–505 (2016).

pubmed: 26959556 pmcid: 4833141 doi: 10.18632/aging.100905

Montes, M. et al. The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotype. Nat. Commun. 12, 2459 (2021).

pubmed: 33911076 pmcid: 8080841 doi: 10.1038/s41467-021-22746-4

Dou, X. et al. PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy. Nat. Metab. 5, 1887–1910 (2023).

pubmed: 37903887 pmcid: 10663165 doi: 10.1038/s42255-023-00912-w

Maus, M. et al. Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype. Nat. Metab. 5, 2111–2130 (2023).

pubmed: 38097808 pmcid: 10730403 doi: 10.1038/s42255-023-00928-2

Fafián-Labora, J. et al. FASN activity is important for the initial stages of the induction of senescence. Cell Death Dis. 10, 318 (2019).

pubmed: 30962418 pmcid: 6453932 doi: 10.1038/s41419-019-1550-0

Flor, A. C., Wolfgeher, D., Wu, D. & Kron, S. J. A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence. Cell Death Discov. 3, 17075 (2017).

pubmed: 29090099 pmcid: 5661608 doi: 10.1038/cddiscovery.2017.75

Liu, X. et al. Oxylipin-PPARγ-initiated adipocyte senescence propagates secondary senescence in the bone marrow. Cell Metab. 35, 667–684.e6 (2023).

pubmed: 37019080 pmcid: 10127143 doi: 10.1016/j.cmet.2023.03.005

Gonçalves, S. et al. COX2 regulates senescence secretome composition and senescence surveillance through PGE2. Cell Rep. 34, 108860 (2021).

pubmed: 33730589 pmcid: 7972992 doi: 10.1016/j.celrep.2021.108860

Ostrowski, M. et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19–30 (2010).

pubmed: 19966785 doi: 10.1038/ncb2000

Yu, X., Harris, S. L. & Levine, A. J. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 66, 4795–4801 (2006).

pubmed: 16651434 doi: 10.1158/0008-5472.CAN-05-4579

Ito, Y., Hoare, M. & Narita, M. Spatial and temporal control of senescence. Trends Cell Biol. 27, 820–832 (2017).

pubmed: 28822679 doi: 10.1016/j.tcb.2017.07.004

Martínez-Zamudio, R. I. et al. AP-1 imprints a reversible transcriptional programme of senescent cells. Nat. Cell Biol. 22, 842–855 (2020).

pubmed: 32514071 pmcid: 7899185 doi: 10.1038/s41556-020-0529-5

Giroud, J. et al. Exploring the communication of the SASP: dynamic, interactive, and adaptive effects on the microenvironment. Int. J. Mol. Sci. 24, 10788 (2023).

pubmed: 37445973 pmcid: 10341516 doi: 10.3390/ijms241310788

Plikus, M. V. et al. Fibroblasts: origins, definitions, and functions in health and disease. Cell 184, 3852–3872 (2021).

pubmed: 34297930 pmcid: 8566693 doi: 10.1016/j.cell.2021.06.024

Casella, G. et al. Transcriptome signature of cellular senescence. Nucleic Acids Res. 47, 11476 (2019).

pubmed: 31612919 pmcid: 6868356 doi: 10.1093/nar/gkz879

Głuchowska, A. et al. Unbiased proteomic analysis of extracellular vesicles secreted by senescent human vascular smooth muscle cells reveals their ability to modulate immune cell functions. GeroScience 44, 2863–2884 (2022).

pubmed: 35900662 pmcid: 9768090 doi: 10.1007/s11357-022-00625-0

Oguma, Y. et al. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics. Cell Commun. Signal. 21, 262 (2023).

pubmed: 37770897 pmcid: 10537976 doi: 10.1186/s12964-023-01280-4

Xu, P. et al. The landscape of human tissue and cell type specific expression and co-regulation of senescence genes. Mol. Neurodegener. 17, 5 (2022).

pubmed: 35000600 pmcid: 8744330 doi: 10.1186/s13024-021-00507-7

Prieto, L. I. et al. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell 41, 1261–1275.e6 (2023).

pubmed: 37267954 doi: 10.1016/j.ccell.2023.05.006

Lee, K.-A., Flores, R. R., Jang, I. H., Saathoff, A. & Robbins, P. D. Immune senescence, immunosenescence and aging. Front. Aging 3, 900028 (2022).

pubmed: 35821850 pmcid: 9261375 doi: 10.3389/fragi.2022.900028

Zhao, Y., Shao, Q. & Peng, G. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment. Cell. Mol. Immunol. 17, 27–35 (2020).

pubmed: 31853000 doi: 10.1038/s41423-019-0344-8

Liu, X. et al. Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition. Nat. Commun. 9, 249 (2018).

pubmed: 29339767 pmcid: 5770447 doi: 10.1038/s41467-017-02689-5

Ye, J. et al. Human regulatory T cells induce T-lymphocyte senescence. Blood 120, 2021–2031 (2012).

pubmed: 22723548 pmcid: 3437594 doi: 10.1182/blood-2012-03-416040

Hall, B. M. et al. p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli. Aging 9, 1867–1884 (2017).

pubmed: 28768895 pmcid: 5611982 doi: 10.18632/aging.101268

Pinney, J. J. et al. Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance. Blood 136, 2065–2079 (2020).

pubmed: 32556153 pmcid: 7596847 doi: 10.1182/blood.2020005571

Ogata, Y. et al. SASP‐induced macrophage dysfunction may contribute to accelerated senescent fibroblast accumulation in the dermis. Exp. Dermatol. 30, 84–91 (2021).

pubmed: 33010063 doi: 10.1111/exd.14205

Liang, S., Domon, H., Hosur, K. B., Wang, M. & Hajishengallis, G. Age-related alterations in innate immune receptor expression and ability of macrophages to respond to pathogen challenge in vitro. Mech. Ageing Dev. 130, 538–546 (2009).

pubmed: 19559723 pmcid: 2717634 doi: 10.1016/j.mad.2009.06.006

Plowden, J. et al. Impaired antigen-induced CD8

pubmed: 15474523 doi: 10.1016/j.cellimm.2004.07.001

Eleftheriadis, T. et al. Dapagliflozin prevents high-glucose-induced cellular senescence in renal tubular epithelial cells. Int. J. Mol. Sci. 23, 16107 (2022).

pubmed: 36555751 pmcid: 9781434 doi: 10.3390/ijms232416107

Zhang, P. et al. Hyperglycemia-induced inflamm-aging accelerates gingival senescence via NLRC4 phosphorylation. J. Biol. Chem. 294, 18807–18819 (2019).

pubmed: 31676687 pmcid: 6901307 doi: 10.1074/jbc.RA119.010648

Nehme, J. et al. High dietary protein and fat contents exacerbate hepatic senescence and SASP in mice. FEBS J. 290, 1340–1347 (2023).

pubmed: 34908245 doi: 10.1111/febs.16292

Baker, D. J. et al. Naturally occurring p16

doi: 10.1038/nature16932

Saul, D. et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat. Commun. 13, 4827 (2022).

pubmed: 35974106 pmcid: 9381717 doi: 10.1038/s41467-022-32552-1

Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978–990 (2013).

pubmed: 23770676 pmcid: 3732483 doi: 10.1038/ncb2784

Teo, Y. V. et al. Notch signaling mediates secondary senescence. Cell Rep. 27, 997–1007.e5 (2019).

pubmed: 31018144 pmcid: 6486482 doi: 10.1016/j.celrep.2019.03.104

Storer, M. et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119–1130 (2013).

pubmed: 24238961 doi: 10.1016/j.cell.2013.10.041

Muñoz-Espín, D. et al. Programmed cell senescence during mammalian embryonic development. Cell 155, 1104–1118 (2013).

pubmed: 24238962 doi: 10.1016/j.cell.2013.10.019

Ritschka, B. et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 31, 172–183 (2017).

pubmed: 28143833 pmcid: 5322731 doi: 10.1101/gad.290635.116

Demaria, M. et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31, 722–733 (2014).

pubmed: 25499914 pmcid: 4349629 doi: 10.1016/j.devcel.2014.11.012

Andrade, A. M. et al. Role of senescent cells in cutaneous wound healing. Biology 11, 1731 (2022).

pubmed: 36552241 pmcid: 9775319 doi: 10.3390/biology11121731

Julier, Z., Park, A. J., Briquez, P. S. & Martino, M. M. Promoting tissue regeneration by modulating the immune system. Acta Biomater. 53, 13–28 (2017).

pubmed: 28119112 doi: 10.1016/j.actbio.2017.01.056

Silva‐Álvarez, S. D. et al. Cell senescence contributes to tissue regeneration in zebrafish. Aging Cell 19, e13052 (2020).

pubmed: 31670873 doi: 10.1111/acel.13052

Kim, S. R. et al. Progressive cellular senescence mediates renal dysfunction in ischemic nephropathy. JASN 32, 1987–2004 (2021).

pubmed: 34135081 pmcid: 8455278 doi: 10.1681/ASN.2020091373

Feng, T. et al. CCN1-induced cellular senescence promotes heart regeneration. Circulation 139, 2495–2498 (2019).

pubmed: 31107624 doi: 10.1161/CIRCULATIONAHA.119.039530

Walters, H. E., Troyanovskiy, K. E., Graf, A. M. & Yun, M. H. Senescent cells enhance newt limb regeneration by promoting muscle dedifferentiation. Aging Cell 22, e13826 (2023).

pubmed: 37025070 pmcid: 10265169 doi: 10.1111/acel.13826

Cuollo, L., Antonangeli, F., Santoni, A. & Soriani, A. The senescence-associated secretory phenotype (SASP) in the challenging future of cancer therapy and age-related diseases. Biology 9, 485 (2020).

pubmed: 33371508 pmcid: 7767554 doi: 10.3390/biology9120485

MacLeod, A. S. & Mansbridge, J. N. The innate immune system in acute and chronic wounds. Adv. Wound Care 5, 65–78 (2016).

doi: 10.1089/wound.2014.0608

Karkanitsa, M., Fathi, P., Ngo, T. & Sadtler, K. Mobilizing endogenous repair through understanding immune reaction with biomaterials. Front. Bioeng. Biotechnol. 9, 730938 (2021).

pubmed: 34917594 pmcid: 8670074 doi: 10.3389/fbioe.2021.730938

Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189 (2006).

pubmed: 16473830 doi: 10.1016/j.immuni.2006.01.001

Qin, H. et al. TGF-β promotes Th17 cell development through inhibition of SOCS3. J. Immunol. 183, 97–105 (2009).

pubmed: 19535626 doi: 10.4049/jimmunol.0801986

Deng, L., Huang, T. & Zhang, L. T cells in idiopathic pulmonary fibrosis: crucial but controversial. Cell Death Discov. 9, 62 (2023).

pubmed: 36788232 pmcid: 9929223 doi: 10.1038/s41420-023-01344-x

Kang, T.-W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547–551 (2011).

pubmed: 22080947 doi: 10.1038/nature10599

Kale, A., Sharma, A., Stolzing, A., Desprez, P.-Y. & Campisi, J. Role of immune cells in the removal of deleterious senescent cells. Immun. Ageing 17, 16 (2020).

pubmed: 32518575 pmcid: 7271494 doi: 10.1186/s12979-020-00187-9

Bennett, M. R. & Clarke, M. C. H. Killing the old: cell senescence in atherosclerosis. Nat. Rev. Cardiol. 14, 8–9 (2017).

doi: 10.1038/nrcardio.2016.195

Salminen, A., Kauppinen, A. & Kaarniranta, K. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence. Biogerontology 19, 325–339 (2018).

pubmed: 29959657 doi: 10.1007/s10522-018-9762-8

McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O’Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87–103 (2015).

pubmed: 25614319 pmcid: 7162685 doi: 10.1038/nri3787

Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246–1256 (2018).

pubmed: 29988130 pmcid: 6082705 doi: 10.1038/s41591-018-0092-9

Suda, M. et al. Senescent cells: a therapeutic target in cardiovascular diseases. Cells 12, 1296 (2023).

pubmed: 37174697 pmcid: 10177324 doi: 10.3390/cells12091296

Schafer, M. J. et al. The senescence-associated secretome as an indicator of age and medical risk. JCI Insight 5, e133668 (2020).

pubmed: 32554926 pmcid: 7406245 doi: 10.1172/jci.insight.133668

Yeh, S. et al. Higher senescence associated secretory phenotype and lower defense mediator in urinary extracellular vesicles of elders with and without Parkinson disease. Sci. Rep. 11, 15783 (2021).

pubmed: 34349163 pmcid: 8339003 doi: 10.1038/s41598-021-95062-y

Shaw, A. C., Goldstein, D. R. & Montgomery, R. R. Age-dependent dysregulation of innate immunity. Nat. Rev. Immunol. 13, 875–887 (2013).

pubmed: 24157572 pmcid: 4096436 doi: 10.1038/nri3547

Weng, N. Aging of the immune system: how much can the adaptive immune system adapt? Immunity 24, 495–499 (2006).

pubmed: 16713964 pmcid: 2266981 doi: 10.1016/j.immuni.2006.05.001

Goronzy, J. J. & Weyand, C. M. Mechanisms underlying T cell ageing. Nat. Rev. Immunol. 19, 573–583 (2019).

pubmed: 31186548 pmcid: 7584388 doi: 10.1038/s41577-019-0180-1

Ashour, D. et al. An interferon gamma response signature links myocardial aging and immunosenescence. Cardiovasc. Res. 119, 2458–2468 (2023).

pubmed: 37141306 pmcid: 10651211 doi: 10.1093/cvr/cvad068

Montecino-Rodriguez, E., Berent-Maoz, B. & Dorshkind, K. Causes, consequences, and reversal of immune system aging. J. Clin. Investig. 123, 958–965 (2013).

pubmed: 23454758 pmcid: 3582124 doi: 10.1172/JCI64096

Loeser, R. F. The role of aging in the development of osteoarthritis. Trans. Am. Clin. Clim. Assoc. 128, 44–54 (2017).

Weyand, C. M. & Goronzy, J. J. Aging of the immune system. mechanisms and therapeutic targets. Ann. Am. Thorac. Soc. 13, S422–S428 (2016).

pubmed: 28005419 pmcid: 5291468 doi: 10.1513/AnnalsATS.201602-095AW

Han, J., Rindone, A. N. & Elisseeff, J. H. Immunoengineering biomaterials for musculoskeletal tissue repair across lifespan. Adv. Mater. https://doi.org/10.1002/adma.202311646 (2024).

doi: 10.1002/adma.202311646 pubmed: 38647521

Wick, G. et al. The immunology of fibrosis: innate and adaptive responses. Trends Immunol. 31, 110–119 (2010).

pubmed: 20106721 pmcid: 3292796 doi: 10.1016/j.it.2009.12.001

Ramani, K. & Biswas, P. S. Interleukin-17: friend or foe in organ fibrosis. Cytokine 120, 282–288 (2019).

pubmed: 30772195 pmcid: 6555688 doi: 10.1016/j.cyto.2018.11.003

Chung, L. et al. Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humans. Sci. Transl. Med. 12, eaax3799 (2020).

pubmed: 32295900 pmcid: 7219543 doi: 10.1126/scitranslmed.aax3799

Wang, L., Chen, S. & Xu, K. IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis. Int. J. Mol. Med. 27, 385–392 (2010).

Selman, M. & Pardo, A. Fibroageing: an ageing pathological feature driven by dysregulated extracellular matrix-cell mechanobiology. Ageing Res. Rev. 70, 101393 (2021).

pubmed: 34139337 doi: 10.1016/j.arr.2021.101393

Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661–665 (2007).

pubmed: 17251932 doi: 10.1038/nature05541

Lujambio, A. et al. Non-cell-autonomous tumor suppression by p53. Cell 153, 449–460 (2013).

pubmed: 23562644 pmcid: 3702034 doi: 10.1016/j.cell.2013.03.020

Ruscetti, M. et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science 362, 1416–1422 (2018).

pubmed: 30573629 pmcid: 6711172 doi: 10.1126/science.aas9090

Ruscetti, M. et al. Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer. Cell 184, 4838–4839 (2021).

pubmed: 34478658 pmcid: 10336720 doi: 10.1016/j.cell.2021.07.028

Goel, S. et al. CDK4/6 inhibition triggers anti-tumor immunity. Nature 548, 471–475 (2017).

pubmed: 28813415 pmcid: 5570667 doi: 10.1038/nature23465

Kim, J. J., Lee, S. B., Park, J. K. & Yoo, Y. D. TNF-α-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL. Cell Death Differ. 17, 1420–1434 (2010).

pubmed: 20203691 doi: 10.1038/cdd.2010.19

Regis, G. et al. IL-6, but not IFN-γ, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing. Leukemia 23, 2102–2108 (2009).

pubmed: 19626047 doi: 10.1038/leu.2009.139

Liu, D. & Hornsby, P. J. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res. 67, 3117–3126 (2007).

pubmed: 17409418 doi: 10.1158/0008-5472.CAN-06-3452

Kim, Y. H. et al. Senescent tumor cells lead the collective invasion in thyroid cancer. Nat. Commun. 8, 15208 (2017).

pubmed: 28489070 pmcid: 5436223 doi: 10.1038/ncomms15208

Fletcher-Sananikone, E. et al. Elimination of radiation-induced senescence in the brain tumor microenvironment attenuates glioblastoma recurrence. Cancer Res. 81, 5935–5947 (2021).

pubmed: 34580063 pmcid: 9724593 doi: 10.1158/0008-5472.CAN-21-0752

Eggert, T. et al. Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression. Cancer Cell 30, 533–547 (2016).

pubmed: 27728804 pmcid: 7789819 doi: 10.1016/j.ccell.2016.09.003

Eyman, D., Damodarasamy, M., Plymate, S. R. & Reed, M. J. CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis. J. Cell. Physiol. 220, 376–381 (2009).

pubmed: 19360811 pmcid: 2846281 doi: 10.1002/jcp.21776

Chen, C. et al. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer. Cell Death Dis. 10, 178 (2019).

pubmed: 30792394 pmcid: 6385313 doi: 10.1038/s41419-019-1431-6

Coppé, J.-P., Kauser, K., Campisi, J. & Beauséjour, C. M. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J. Biol. Chem. 281, 29568–29574 (2006).

pubmed: 16880208 doi: 10.1074/jbc.M603307200

Hickson, L. J. et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446–456 (2019).

pubmed: 31542391 pmcid: 6796530 doi: 10.1016/j.ebiom.2019.08.069

Zhu, Y. et al. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans. EBioMedicine 77, 103912 (2022).

pubmed: 35292270 pmcid: 9034457 doi: 10.1016/j.ebiom.2022.103912

Aversa, Z. et al. Biomarkers of cellular senescence in idiopathic pulmonary fibrosis. Respir. Res. 24, 101 (2023).

pubmed: 37029417 pmcid: 10080755 doi: 10.1186/s12931-023-02403-8

Sorokina, A. G. et al. Correlations between biomarkers of senescent cell accumulation at the systemic, tissue and cellular levels in elderly patients. Exp. Gerontol. 177, 112176 (2023).

pubmed: 37080342 doi: 10.1016/j.exger.2023.112176

St Sauver, J. L. et al. Biomarkers of cellular senescence and risk of death in humans. Aging Cell 22, e14006 (2023).

pubmed: 37803875 pmcid: 10726868 doi: 10.1111/acel.14006

Lin, Y. et al. Circulating monocytes expressing senescence‐associated features are enriched in COVID‐19 patients with severe disease. Aging Cell 22, e14011 (2023).

pubmed: 37969056 pmcid: 10726854 doi: 10.1111/acel.14011

Laberge, R. et al. Glucocorticoids suppress selected components of the senescence‐associated secretory phenotype. Aging Cell 11, 569–578 (2012).

pubmed: 22404905 doi: 10.1111/j.1474-9726.2012.00818.x

Moiseeva, O. et al. Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation. Aging Cell 12, 489–498 (2013).

pubmed: 23521863 doi: 10.1111/acel.12075

Abdelgawad, I. Y., Agostinucci, K., Sadaf, B., Grant, M. K. O. & Zordoky, B. N. Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in doxorubicin-induced senescent endothelial cells. Front. Aging 4, 1170434 (2023).

pubmed: 37168843 pmcid: 10164964 doi: 10.3389/fragi.2023.1170434

Frediani, E. et al. Olive phenols preserve lamin B1 expression reducing cGAS/STING/NFκB‐mediated SASP in ionizing radiation‐induced senescence. J. Cell. Mol. Med. 26, 2337–2350 (2022).

pubmed: 35278036 pmcid: 8995441 doi: 10.1111/jcmm.17255

Alimbetov, D. et al. Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2. Biogerontology 17, 305–315 (2016).

pubmed: 26400758 doi: 10.1007/s10522-015-9610-z

Yao, Z. et al. Therapy-induced senescence drives bone loss. Cancer Res. 80, 1171–1182 (2020).

pubmed: 31932453 pmcid: 7056549 doi: 10.1158/0008-5472.CAN-19-2348

Wang, R. et al. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2‐independent mechanism. Aging Cell 16, 564–574 (2017).

pubmed: 28371119 pmcid: 5418203 doi: 10.1111/acel.12587

Roh, K. et al. Lysosomal control of senescence and inflammation through cholesterol partitioning. Nat. Metab. 5, 398–413 (2023).

pubmed: 36864206 doi: 10.1038/s42255-023-00747-5

Liu, S. et al. Resveratrol reduces senescence-associated secretory phenotype by SIRT1/NF-κB pathway in gut of the annual fish Nothobranchius guentheri. Fish Shellfish Immunol. 80, 473–479 (2018).

pubmed: 29908321 doi: 10.1016/j.fsi.2018.06.027

Luo, X. et al. Stromal-initiated changes in the bone promote metastatic niche development. Cell Rep. 14, 82–92 (2016).

pubmed: 26725121 doi: 10.1016/j.celrep.2015.12.016

di Martino, S. et al. HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome. Oncogene 37, 1369–1385 (2018).

pubmed: 29311642 doi: 10.1038/s41388-017-0044-8

Perrott, K. M., Wiley, C. D., Desprez, P.-Y. & Campisi, J. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. GeroScience 39, 161–173 (2017).

pubmed: 28378188 pmcid: 5411372 doi: 10.1007/s11357-017-9970-1

Georgilis, A. et al. PTBP1-mediated alternative splicing regulates the inflammatory secretome and the pro-tumorigenic effects of senescent cells. Cancer Cell 34, 85–102.e9 (2018).

pubmed: 29990503 pmcid: 6048363 doi: 10.1016/j.ccell.2018.06.007

Ogrodnik, M. et al. Obesity-induced cellular senescence drives anxiety and impairs neurogenesis. Cell Metab. 29, 1061–1077.e8 (2019).

pubmed: 30612898 pmcid: 6509403 doi: 10.1016/j.cmet.2018.12.008

Salas-Venegas, V. et al. Chronic consumption of a hypercaloric diet increases neuroinflammation and brain senescence, promoting cognitive decline in middle-aged female Wistar rats. Front. Aging Neurosci. 15, 1162747 (2023).

pubmed: 37139092 pmcid: 10149996 doi: 10.3389/fnagi.2023.1162747

Maeda, M., Hayashi, T., Mizuno, N., Hattori, Y. & Kuzuya, M. Intermittent high glucose implements stress-induced senescence in human vascular endothelial cells: role of superoxide production by NADPH oxidase. PLoS One 10, e0123169 (2015).

pubmed: 25879533 pmcid: 4400006 doi: 10.1371/journal.pone.0123169

Wang, W., Cai, G. & Chen, X. Dietary restriction delays the secretion of senescence associated secretory phenotype by reducing DNA damage response in the process of renal aging. Exp. Gerontol. 107, 4–10 (2018).

pubmed: 28916310 doi: 10.1016/j.exger.2017.09.005

Fontana, L. et al. The effects of graded caloric restriction: XII. Comparison of mouse to human impact on cellular senescence in the colon. Aging Cell 17, e12746 (2018).

pubmed: 29575469 pmcid: 5946078 doi: 10.1111/acel.12746

Erlangga, Z. et al. The effect of prolonged intermittent fasting on autophagy, inflammasome and senescence genes expressions: an exploratory study in healthy young males. Hum. Nutr. Metab. 32, 200189 (2023).

doi: 10.1016/j.hnm.2023.200189

Englund, D. A. et al. Exercise reduces circulating biomarkers of cellular senescence in humans. Aging Cell 20, e13415 (2021).

pubmed: 34101960 pmcid: 8282238 doi: 10.1111/acel.13415

Demaria, M. et al. Long-term intensive endurance exercise training is associated to reduced markers of cellular senescence in the colon mucosa of older adults. NPJ Aging 9, 3 (2023).

pubmed: 36849522 pmcid: 9971019 doi: 10.1038/s41514-023-00100-w

Meng, J. et al. Exercise protects vascular function by countering senescent cells in older adults. Front. Physiol. 14, 1138162 (2023).

pubmed: 37089434 pmcid: 10118010 doi: 10.3389/fphys.2023.1138162

Schafer, M. J. et al. Cellular senescence mediates fibrotic pulmonary disease. Nat. Commun. 8, 14532 (2017).

pubmed: 28230051 pmcid: 5331226 doi: 10.1038/ncomms14532

Wang, B., Kohli, J. & Demaria, M. Senescent cells in cancer therapy: friends or foes? Trends Cancer 6, 838–857 (2020).

pubmed: 32482536 doi: 10.1016/j.trecan.2020.05.004

Pereira, B. I. et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8

pubmed: 31160572 pmcid: 6547655 doi: 10.1038/s41467-019-10335-5

Ruhland, M. K. et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat. Commun. 7, 11762 (2016).

pubmed: 27272654 pmcid: 4899869 doi: 10.1038/ncomms11762

Ferrucci, L. et al. Serum IL‐6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 47, 639–646 (1999).

pubmed: 10366160 doi: 10.1111/j.1532-5415.1999.tb01583.x

Khavinson, V., Linkova, N., Dyatlova, A., Kantemirova, R. & Kozlov, K. Senescence-associated secretory phenotype of cardiovascular system cells and inflammaging: perspectives of peptide regulation. Cells 12, 106 (2022).

pubmed: 36611900 pmcid: 9818427 doi: 10.3390/cells12010106

Jeon, O. H. et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 23, 775–781 (2017).

pubmed: 28436958 pmcid: 5785239 doi: 10.1038/nm.4324

The senescence-associated secretory phenotype and its physiological and pathological implications.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Boshi Wang (B)

Jin Han (J)

Jennifer H Elisseeff (JH)

Marco Demaria (M)

Classifications MeSH